[Home ] [Archive]    
:: Main Online Submission Archive Current Issue In Press ::
:: Volume 11, Issue 4 (Winter 2010) ::
ZJRMS 2010, 11(4): 0-0 Back to browse issues page
Combined Therapy with Desferal and Deferioprone in Improvement of Heart Function in Thalassemic Patients
Noor M. Noori, Peyman Eshghi, Iraj Shahramian
Abstract:   (10117 Views)

  Background: Cardiac complications due to iron overload are the most common causes of death in patients with major thalassemia. This study assessed the efficacy of iron chelating by desferal-L1 in improvement of cardiac function in patients with major thalassemia.

  Methods and Materials : Patients older then 8 years old with major thalassemia that were admitted to hematology ward of Ali-e-Asghar hospital of Zahedan in 2005-2006 and had lower than normal diastolic indices in annual echocardiography were considered as study population. During primary tests, indices of diastolic function of left and right hearts were calculated, using echocardiography with 2D, M-mode and Doppler then the patients were placed on a combination of desferal (30-40mg/kg/day two nights per week) and L1 (deferiprone) (75mg/kg/day, three times a day). At the end of the study, cardiac indices were calculated again. Data were using SPSS software and paired t-test and p <0.05 was considered as significant level.

  Results : Of 38 patients, who were treated with a combination of desferal-L1, 19 were female with the mean age of 16.9 ± 3.1 and 18 were male with the mean age of 17.3 ± 2.6 years. Diastolic indices of right ventricle had no significant difference before and after treatment except PET/ET which decreased significantly after treatment ( p <0.05). Of diastolic indices of left ventricule peak-E-velocity and IVRT and E/A ratio decreased significantly after treatment ( p <0.05). t he difference of peak-A-velocity before and after treatment was not significant ( p >0.05). Systolic indices of left ventricule increased significantly after treatment ( p <0.05).

  Conclusion : In this study, after one year of treatment with a combination of desferal-L1 in patients with major thalassemia, echocardiography showed improvement in left heart systolic and diastolic function. This combination therapy prevented progression of right ventricular diastolic function abnormality.

  

Keywords: Keywords: Major beta thalassemia, e chocardiography, d esferal, d eferiprone
Full-Text [PDF 248 kb]   (3276 Downloads)    
Type of Study: Research | Subject: Pediatrics
* Corresponding Author Address: Resident of Pediatrics, Research Center for Children and Adolescent's Health, Zahedan University of Medical Sciences, Zahedan, Iran.Ir_buper@yahoo.com
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Noori N M, Eshghi P, Shahramian I. Combined Therapy with Desferal and Deferioprone in Improvement of Heart Function in Thalassemic Patients. ZJRMS. 2010; 11 (4)
URL: http://zjrms.ir/article-1-502-en.html


Volume 11, Issue 4 (Winter 2010) Back to browse issues page
Zahedan Journal of Research in Medical Sciences
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 3921